XTB has done something unusual in the days since its record H1 results landed on August 28: it rose anyway, gaining another 7.5% on the week to close at PLN 180.84, extending the 30% monthly surge and moving even further above the analyst consensus that the stock already outran before the print.
The post-results move is worth pausing on. Three recent earnings events showed how wide the range of reactions can be. The July 30 release triggered a 9.4% one-day jump and a 22.6% five-day follow-through. The August 7 reading barely moved on the day before recovering to a 5.8% five-day gain. Earlier this year, one print produced a 5.1% one-day drop. This week's continuation of the rally after August 28 results puts XTB firmly in the positive-reaction camp — the stock added to gains rather than giving them back, which is notable given how much was already priced in before the announcement.
The lending market remains as clear as it has been all summer: there is simply no short-selling pressure here. Borrow availability is running near 8,800%, meaning roughly 88 shares sit available to borrow for every one currently lent out — a level that has barely moved since the previous notes flagged it in mid-August. That extraordinary looseness has accompanied a steady drift lower in short activity since late June, when availability was around 1,750%. Borrow cost is holding near 0.91%, up about 5% on the week but still firmly in the low-single-digit range that signals no squeeze risk. The ORTEX short score of 25.4 ranks in the 94th percentile on the factor model — meaning XTB carries less short pressure than all but a handful of comparable stocks.
Valuation has re-rated meaningfully alongside the price. The price-to-earnings multiple has climbed to 11.6x, up roughly 0.9 turns on the week and 0.6 turns over the past month — modest expansion in absolute terms but notable for a stock already up 30% in a month. Price-to-book has moved to 7.2x, adding 1.8 turns over 30 days. Against that, the earnings yield still reads above 8.6%, which is not demanding for a business that just doubled its net profit year-on-year. The factor model scores reflect the momentum story: EPS momentum ranks in the 99th percentile, and the dividend score sits at 95 — though the dividend history on record is stale and should not be read as current yield guidance. The analyst mean target of PLN 163.18 is now almost 10% below the current price, a gap that has widened further since the pre-results notes flagged the stock running through consensus. That staleness caveat matters: the target data is 25 days old and predates the confirmed record results, so it likely understates where the Street will land once updates come through.
Among correlated peers, the week's direction was broadly constructive. SQN added 6.5% and PBEE gained more than 10%. PALI surged 16% on different catalysts. RJF rose 2.4%. XTB's 7.5% weekly gain sits comfortably in the upper half of the peer group, consistent with the momentum the stock has built over a month rather than a single session.
The question the tape now frames is straightforward: whether a stock that has run 30% in a month, doubled its annual profit, and outrun every analyst target can sustain that pace into a November earnings date that is still three months away. The next anchor for the story is how quickly the Street refreshes its targets in response to confirmed H1 numbers — and whether those new targets catch up to where the price already is.
See the live data behind this article on ORTEX.
Open XTB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
